2022年6期
Journal of Pharmaceutical Analysis
Original Articles
- Corrigendum to“The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection:A review”[J.Pharma.Anal.11(2021)265-271]
- A highly efficient protein corona-based proteomic analysis strategy for the discovery of pharmacodynamic biomarkers
- LC-MS/MS method for the quantitation of serum tocilizumab in rheumatoid arthritis patients using rapid tryptic digestion without IgG purification
- Development of a surface plasmon resonance biosensor for accurate and sensitive quantitation of small molecules in blood samples
- Discovery of pulmonary fibrosis inhibitor targeting TGF-βRI in Polygonum cuspidatum by high resolution mass spectrometry with in silico strategy
- Fluorescent aptasensor for detection of live foodborne pathogens based on multicolor perovskite-quantum-dot-encoded DNA probes and dual-stirring-bar-assisted signal amplification
- Identification of potential anti-pneumonia pharmacologicalcomponents of Glycyrrhizae Radix et Rhizoma after the treatment with Gan An He Ji oral liquid
- Development of a radiolabeled site-specific single-domain antibody positron emission tomography probe for monitoring PD-L1 expression in cancer
- Tumor-targeting intravenous lipid emulsion of paclitaxel:Characteristics,stability,toxicity,and toxicokinetics
- Rabdosia serra alleviates dextran sulfate sodium salt-induced colitis in mice through anti-inflammation,regulating Th17/Treg balance,maintaining intestinal barrier integrity,and modulating gut microbiota
- Metabolomic and elemental profiling of blood serum in bladder cancer
- Peptide-RNA complexation-induced fluorescence“turn on”displacement assay for the recognition of small ligands targeting HIV-1 RNA